Brief: Iconovo Completes Study Of Icores Budesonide/Formoterol

Iconovo AB

09/02/2022 09:42

Feb 9 (Reuters) - Iconovo AB  ICO.ST :
    * ANNOUNCES COMPLETION OF COMPARATIVE CLINICAL STUDY OF
ICORES
BUDESONIDE/FORMOTEROL AND SYMBICORT TURBUHALER
    * PROGRAM IS STILL ON TRACK TO ALLOW A FILING FOR MARKET
APPROVAL
IN EU DURING 2023
    * EXPECTS POTENTIAL PRODUCT LAUNCH IN 2024

Source text for Eikon:  ID:nMFN5h9t8v 
Further company coverage:  ICO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))